BDBM50389704 CHEMBL2070081::US10544104, Compound 150::US9518026, Example 9::US9765037, Compound 150::US9956214, Compound 9

SMILES CCOc1ccc2cc(ccc2c1)-c1nn(CC2CCN(C)CC2)c2ncnc(N)c12

InChI Key InChIKey=KONPIFGGWNMOKY-UHFFFAOYSA-N

Data  19 IC50

PDB links: 1 PDB ID matches this monomer.

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 19 hits for monomerid = 50389704   

TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  4.60E+3nMAssay Description:Inhibition of human ABL using EAIYAAPFAKKK-OH as substrate by phosphorimaging methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProto-oncogene tyrosine-protein kinase Src(Gallus gallus (Chicken))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of chicken Src using AcEIYGEFKKK as substrate after 90 mins in presence of ATP by luciferase reporter gene assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMitogen-activated protein kinase 14(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human p38alpha using myelin basic protein as substrate after 180 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEphrin type-A receptor 3(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human EPHA3 using myelin basic protein as substrate after 120 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase CSK(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetEpidermal growth factor receptor(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human EGFR using poly glu-Tyr as substrate after 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human SRC using Ac-EIYGEFKKK-OH as substrate after 60 mins by phosphorimaging methodMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
University Of Washington Through Its Center For Commercialization

US Patent
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
TargetUncharacterized protein(Cryptosporidium parvum)
University Of Washington Through Its Center For Commercialization

US Patent
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  1nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of human tyrosine kinases.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >3.00E+3nMAssay Description:Inhibition of human tyrosine kinases.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
University Of Washington Through Its Center For Commercialization

US Patent
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
TargetCalcium-dependent protein kinase 1(Cryptosporidium parvum)
University Of Washington Through Its Center For Commercialization

US Patent
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  1nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCalcium-dependent protein kinase 4(Plasmodium falciparum (isolate 3D7))
TBA

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  10nMAssay Description:Inhibition of Plasmodium falciparum CDPK4 using syntide-2 as substrate by luminescence assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50: >3.00E+3nMAssay Description:Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCalmodulin-domain protein kinase 1(Toxoplasma gondii)
University Of Washington Through Its Center For Commercialization

US Patent
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  2.90nMAssay Description:Inhibition of recombinant Toxoplasma gondii CDPK1 using Biotin-C6-PLARTLSVAGLPGKK as substrate after 90 mins in presence of ATP by luciferase reporte...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  400nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase Lck(Homo sapiens (Human))
University Of Washington

Curated by ChEMBL
LigandPNGBDBM50389704(CHEMBL2070081 | US10544104, Compound 150 | US95180...)
Affinity DataIC50:  3.30E+3nMAssay Description:Inhibition of human LCK using Ac-EIYGEFKKK-OH as substrate after 60 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed